Remove Drug Development Remove Pharma R&D Remove Treatment
article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

In a statement, the EFPIA said AI will have an ever more critical role in the research, development and manufacturing of medicinal products, allowing the discovery, development and delivery of new, safer, more effective treatments to patients faster than ever before.

article thumbnail

Rethinking the pharma R&D lifecycle with AI in mind

Drug Discovery World

Sound clinical trial design requires randomisation, but that takes participants out of the driver’s seat — they no longer have final say over their treatment decisions, creating a barrier to recruitment.